 | • レポートコード：QYR2104Z1299 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、胆管炎のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（急性胆管炎、原発性硬化性胆管炎、続発性硬化性胆管炎、再発性化膿性胆管炎）、用途別市場規模（臨床実習、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・胆管炎の市場動向 ・企業の競争状況、市場シェア ・胆管炎の種類別市場規模（急性胆管炎、原発性硬化性胆管炎、続発性硬化性胆管炎、再発性化膿性胆管炎） ・胆管炎の用途別市場規模（臨床実習、その他） ・胆管炎の北米市場規模2016-2027（アメリカ、カナダ） ・胆管炎のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・胆管炎のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胆管炎の中南米市場規模2016-2027（メキシコ、ブラジル） ・胆管炎の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Taiho Pharmaceutical、Mayo Clinic、Bayer、Gilead Sciences、RiemserArzneimittel、Zambon） ・結論 |
Cholangitis is an infection of the biliary tract with the potential to cause significant morbidity and mortality.
The key factors contributing to the growth of the cholangitis market are the changing lifestyle, increasing awareness of healthcare and geriatric population increase.
Market Analysis and Insights: Global Cholangitis Market
The global Cholangitis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cholangitis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cholangitis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cholangitis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cholangitis market.
Global Cholangitis Scope and Market Size
Cholangitis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cholangitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Acute Cholangitis
Primary Sclerosing Cholangitis
Secondary Sclerosing Cholangitis
Recurrent Pyogenic Cholangitis
Segment by Application
Clinical Practise
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Taiho Pharmaceutical
Mayo Clinic
Bayer
Gilead Sciences
RiemserArzneimittel
Zambon
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cholangitis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Acute Cholangitis
1.2.3 Primary Sclerosing Cholangitis
1.2.4 Secondary Sclerosing Cholangitis
1.2.5 Recurrent Pyogenic Cholangitis
1.3 Market by Application
1.3.1 Global Cholangitis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Practise
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cholangitis Market Perspective (2016-2027)
2.2 Cholangitis Growth Trends by Regions
2.2.1 Cholangitis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cholangitis Historic Market Share by Regions (2016-2021)
2.2.3 Cholangitis Forecasted Market Size by Regions (2022-2027)
2.3 Cholangitis Industry Dynamic
2.3.1 Cholangitis Market Trends
2.3.2 Cholangitis Market Drivers
2.3.3 Cholangitis Market Challenges
2.3.4 Cholangitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cholangitis Players by Revenue
3.1.1 Global Top Cholangitis Players by Revenue (2016-2021)
3.1.2 Global Cholangitis Revenue Market Share by Players (2016-2021)
3.2 Global Cholangitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cholangitis Revenue
3.4 Global Cholangitis Market Concentration Ratio
3.4.1 Global Cholangitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cholangitis Revenue in 2020
3.5 Cholangitis Key Players Head office and Area Served
3.6 Key Players Cholangitis Product Solution and Service
3.7 Date of Enter into Cholangitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cholangitis Breakdown Data by Type
4.1 Global Cholangitis Historic Market Size by Type (2016-2021)
4.2 Global Cholangitis Forecasted Market Size by Type (2022-2027)
5 Cholangitis Breakdown Data by Application
5.1 Global Cholangitis Historic Market Size by Application (2016-2021)
5.2 Global Cholangitis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cholangitis Market Size (2016-2027)
6.2 North America Cholangitis Market Size by Type
6.2.1 North America Cholangitis Market Size by Type (2016-2021)
6.2.2 North America Cholangitis Market Size by Type (2022-2027)
6.2.3 North America Cholangitis Market Size by Type (2016-2027)
6.3 North America Cholangitis Market Size by Application
6.3.1 North America Cholangitis Market Size by Application (2016-2021)
6.3.2 North America Cholangitis Market Size by Application (2022-2027)
6.3.3 North America Cholangitis Market Size by Application (2016-2027)
6.4 North America Cholangitis Market Size by Country
6.4.1 North America Cholangitis Market Size by Country (2016-2021)
6.4.2 North America Cholangitis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cholangitis Market Size (2016-2027)
7.2 Europe Cholangitis Market Size by Type
7.2.1 Europe Cholangitis Market Size by Type (2016-2021)
7.2.2 Europe Cholangitis Market Size by Type (2022-2027)
7.2.3 Europe Cholangitis Market Size by Type (2016-2027)
7.3 Europe Cholangitis Market Size by Application
7.3.1 Europe Cholangitis Market Size by Application (2016-2021)
7.3.2 Europe Cholangitis Market Size by Application (2022-2027)
7.3.3 Europe Cholangitis Market Size by Application (2016-2027)
7.4 Europe Cholangitis Market Size by Country
7.4.1 Europe Cholangitis Market Size by Country (2016-2021)
7.4.2 Europe Cholangitis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cholangitis Market Size (2016-2027)
8.2 Asia-Pacific Cholangitis Market Size by Type
8.2.1 Asia-Pacific Cholangitis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cholangitis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cholangitis Market Size by Type (2016-2027)
8.3 Asia-Pacific Cholangitis Market Size by Application
8.3.1 Asia-Pacific Cholangitis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cholangitis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cholangitis Market Size by Application (2016-2027)
8.4 Asia-Pacific Cholangitis Market Size by Region
8.4.1 Asia-Pacific Cholangitis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cholangitis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cholangitis Market Size (2016-2027)
9.2 Latin America Cholangitis Market Size by Type
9.2.1 Latin America Cholangitis Market Size by Type (2016-2021)
9.2.2 Latin America Cholangitis Market Size by Type (2022-2027)
9.2.3 Latin America Cholangitis Market Size by Type (2016-2027)
9.3 Latin America Cholangitis Market Size by Application
9.3.1 Latin America Cholangitis Market Size by Application (2016-2021)
9.3.2 Latin America Cholangitis Market Size by Application (2022-2027)
9.3.3 Latin America Cholangitis Market Size by Application (2016-2027)
9.4 Latin America Cholangitis Market Size by Country
9.4.1 Latin America Cholangitis Market Size by Country (2016-2021)
9.4.2 Latin America Cholangitis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cholangitis Market Size (2016-2027)
10.2 Middle East & Africa Cholangitis Market Size by Type
10.2.1 Middle East & Africa Cholangitis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cholangitis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cholangitis Market Size by Type (2016-2027)
10.3 Middle East & Africa Cholangitis Market Size by Application
10.3.1 Middle East & Africa Cholangitis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cholangitis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cholangitis Market Size by Application (2016-2027)
10.4 Middle East & Africa Cholangitis Market Size by Country
10.4.1 Middle East & Africa Cholangitis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cholangitis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Taiho Pharmaceutical
11.1.1 Taiho Pharmaceutical Company Details
11.1.2 Taiho Pharmaceutical Business Overview
11.1.3 Taiho Pharmaceutical Cholangitis Introduction
11.1.4 Taiho Pharmaceutical Revenue in Cholangitis Business (2016-2021)
11.1.5 Taiho Pharmaceutical Recent Development
11.2 Mayo Clinic
11.2.1 Mayo Clinic Company Details
11.2.2 Mayo Clinic Business Overview
11.2.3 Mayo Clinic Cholangitis Introduction
11.2.4 Mayo Clinic Revenue in Cholangitis Business (2016-2021)
11.2.5 Mayo Clinic Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Cholangitis Introduction
11.3.4 Bayer Revenue in Cholangitis Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Details
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Cholangitis Introduction
11.4.4 Gilead Sciences Revenue in Cholangitis Business (2016-2021)
11.4.5 Gilead Sciences Recent Development
11.5 RiemserArzneimittel
11.5.1 RiemserArzneimittel Company Details
11.5.2 RiemserArzneimittel Business Overview
11.5.3 RiemserArzneimittel Cholangitis Introduction
11.5.4 RiemserArzneimittel Revenue in Cholangitis Business (2016-2021)
11.5.5 RiemserArzneimittel Recent Development
11.6 Zambon
11.6.1 Zambon Company Details
11.6.2 Zambon Business Overview
11.6.3 Zambon Cholangitis Introduction
11.6.4 Zambon Revenue in Cholangitis Business (2016-2021)
11.6.5 Zambon Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cholangitis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Acute Cholangitis
Table 3. Key Players of Primary Sclerosing Cholangitis
Table 4. Key Players of Secondary Sclerosing Cholangitis
Table 5. Key Players of Recurrent Pyogenic Cholangitis
Table 6. Global Cholangitis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cholangitis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cholangitis Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cholangitis Market Share by Regions (2016-2021)
Table 10. Global Cholangitis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cholangitis Market Share by Regions (2022-2027)
Table 12. Cholangitis Market Trends
Table 13. Cholangitis Market Drivers
Table 14. Cholangitis Market Challenges
Table 15. Cholangitis Market Restraints
Table 16. Global Cholangitis Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cholangitis Market Share by Players (2016-2021)
Table 18. Global Top Cholangitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholangitis as of 2020)
Table 19. Ranking of Global Top Cholangitis Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cholangitis Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cholangitis Product Solution and Service
Table 23. Date of Enter into Cholangitis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cholangitis Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cholangitis Revenue Market Share by Type (2016-2021)
Table 27. Global Cholangitis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cholangitis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cholangitis Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cholangitis Revenue Market Share by Application (2016-2021)
Table 31. Global Cholangitis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cholangitis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cholangitis Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cholangitis Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cholangitis Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cholangitis Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cholangitis Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cholangitis Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cholangitis Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cholangitis Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cholangitis Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cholangitis Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cholangitis Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cholangitis Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cholangitis Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cholangitis Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cholangitis Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cholangitis Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cholangitis Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cholangitis Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cholangitis Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cholangitis Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cholangitis Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cholangitis Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cholangitis Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cholangitis Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cholangitis Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cholangitis Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cholangitis Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cholangitis Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cholangitis Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cholangitis Market Size by Country (2022-2027) & (US$ Million)
Table 63. Taiho Pharmaceutical Company Details
Table 64. Taiho Pharmaceutical Business Overview
Table 65. Taiho Pharmaceutical Cholangitis Product
Table 66. Taiho Pharmaceutical Revenue in Cholangitis Business (2016-2021) & (US$ Million)
Table 67. Taiho Pharmaceutical Recent Development
Table 68. Mayo Clinic Company Details
Table 69. Mayo Clinic Business Overview
Table 70. Mayo Clinic Cholangitis Product
Table 71. Mayo Clinic Revenue in Cholangitis Business (2016-2021) & (US$ Million)
Table 72. Mayo Clinic Recent Development
Table 73. Bayer Company Details
Table 74. Bayer Business Overview
Table 75. Bayer Cholangitis Product
Table 76. Bayer Revenue in Cholangitis Business (2016-2021) & (US$ Million)
Table 77. Bayer Recent Development
Table 78. Gilead Sciences Company Details
Table 79. Gilead Sciences Business Overview
Table 80. Gilead Sciences Cholangitis Product
Table 81. Gilead Sciences Revenue in Cholangitis Business (2016-2021) & (US$ Million)
Table 82. Gilead Sciences Recent Development
Table 83. RiemserArzneimittel Company Details
Table 84. RiemserArzneimittel Business Overview
Table 85. RiemserArzneimittel Cholangitis Product
Table 86. RiemserArzneimittel Revenue in Cholangitis Business (2016-2021) & (US$ Million)
Table 87. RiemserArzneimittel Recent Development
Table 88. Zambon Company Details
Table 89. Zambon Business Overview
Table 90. Zambon Cholangitis Product
Table 91. Zambon Revenue in Cholangitis Business (2016-2021) & (US$ Million)
Table 92. Zambon Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cholangitis Market Share by Type: 2020 VS 2027
Figure 2. Acute Cholangitis Features
Figure 3. Primary Sclerosing Cholangitis Features
Figure 4. Secondary Sclerosing Cholangitis Features
Figure 5. Recurrent Pyogenic Cholangitis Features
Figure 6. Global Cholangitis Market Share by Application: 2020 VS 2027
Figure 7. Clinical Practise Case Studies
Figure 8. Others Case Studies
Figure 9. Cholangitis Report Years Considered
Figure 10. Global Cholangitis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cholangitis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cholangitis Market Share by Regions: 2020 VS 2027
Figure 13. Global Cholangitis Market Share by Regions (2022-2027)
Figure 14. Global Cholangitis Market Share by Players in 2020
Figure 15. Global Top Cholangitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cholangitis as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cholangitis Revenue in 2020
Figure 17. Global Cholangitis Revenue Market Share by Type (2016-2021)
Figure 18. Global Cholangitis Revenue Market Share by Type (2022-2027)
Figure 19. North America Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cholangitis Market Share by Type (2016-2027)
Figure 21. North America Cholangitis Market Share by Application (2016-2027)
Figure 22. North America Cholangitis Market Share by Country (2016-2027)
Figure 23. United States Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cholangitis Market Share by Type (2016-2027)
Figure 27. Europe Cholangitis Market Share by Application (2016-2027)
Figure 28. Europe Cholangitis Market Share by Country (2016-2027)
Figure 29. Germany Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cholangitis Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cholangitis Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cholangitis Market Share by Region (2016-2027)
Figure 39. China Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cholangitis Market Share by Type (2016-2027)
Figure 47. Latin America Cholangitis Market Share by Application (2016-2027)
Figure 48. Latin America Cholangitis Market Share by Country (2016-2027)
Figure 49. Mexico Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cholangitis Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cholangitis Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cholangitis Market Share by Country (2016-2027)
Figure 55. Turkey Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cholangitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Taiho Pharmaceutical Revenue Growth Rate in Cholangitis Business (2016-2021)
Figure 59. Mayo Clinic Revenue Growth Rate in Cholangitis Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Cholangitis Business (2016-2021)
Figure 61. Gilead Sciences Revenue Growth Rate in Cholangitis Business (2016-2021)
Figure 62. RiemserArzneimittel Revenue Growth Rate in Cholangitis Business (2016-2021)
Figure 63. Zambon Revenue Growth Rate in Cholangitis Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
世界の再発性多形性膠芽腫（GBM）治療市場規模・現状・予測（2021年-2027年） Recurrent glioblastoma multiforme is the most aggressive cancer that begins within the brain. The increasing incidence of seizure is expected to drive the recurrent glioblastoma multiforme treatment market. Market Analysis and Insights: Global Recurrent Glioblastoma Multiforme (GBM) Treatment Market…- 世界の再発性多形性膠芽腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Recurrent Glioblastoma Multiforme Treatment Market The global Recurrent Glioblastoma Multiforme Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in …
- 世界の急性・慢性異常子宮出血（AUB）市場規模・現状・予測（2021年-2027年） Abnormal uterine bleeding (AUB) may be acute or chronic and is defined as bleeding from the uterine corpus that is abnormal in regularity, volume, frequency, or duration and occurs in the absence of pregnancy. Market Analysis and Insights: Global Acute and Chronic Abnormal Uterine Bleeding Market Th…
- 世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…
- 世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…